“…The aim of this study was to empirically measure longitudinal change of the risk scales and risk factors of the HKT-R in 341 male patients after 2 years of treatment in the two FPCs in Flanders. Based on group-level analyses, the clinical scale did not change significantly, contrary to findings of previous literature that reported a significant small decline (Belfrage & Douglas, 2002; De Jonge et al, 2009; Hogan & Olver, 2016, 2019; Janković et al, 2021; Jeandarme et al, 2017; Mastromanno et al, 2018; Morrissey et al, 2014; O’Shea & Dickens, 2015; Olsson et al, 2013; Richter et al, 2018; Van der Linde et al, 2020). Furthermore, a decline was observed in only one clinical factor.…”